TCT 2021: OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG | Dr David E. Kandzari скачать в хорошем качестве

TCT 2021: OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG | Dr David E. Kandzari

Watch the full video on Radcliffe Cardiology here: https://www.radcliffecardiology.com/v... In this short video, Dr David E Kandzari (Piedmont Heart Institute, Atlanta, GA, US) discusses the easy outcomes from the OPTIMUM registry. The registry is a minimal risk observational study that uses a prospective cohort design to follow patients who have multivessel or left main coronary artery disease (CAD) and are deemed ineligible for coronary artery bypass surgery. The findings, presented first at TCT 21, underscore the potential of revascularization to improve patients’ health status if it can be performed safely, even if surgery is not an option. Discussion Points -Rationale of the Study -Gaps in Guidelines -Study Design and Eligibility Criteria -Key Results -Take-home Messages -Next Steps Recorded remotely from Atlanta, 2021. Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.